Here are five observations:
1. A rising number of neurological disorders, increasing available technologies, growing awareness of brain diseases, improving infrastructure and increasing research drive North America’s market growth.
2. Asia will see high growth in the next few years because of growing research and development, increasing financial support from government and improving treatments and infrastructure.
3. India, China and Japan will lead the market growth in Asia, due to growing economies.
4. Equipment costs, regulatory requirements and poor reimbursements will hinder market growth.
5. Trends in the market include the adoption of neurostimulation devices, more mergers and acquisitions, quick product launches and more partnerships.
More articles on devices:
Nexxt Spine develops DT Elite Guide System: 4 things to know
Prosidyan’s synthetic bone graft substitute receives FDA clearance: 4 things to note
Center for Regenerative Orthopedics offers platelet rich plasma therapy for arthritis, overuse injuries — 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
